gocovri
Generic: amantadine
gocovri: developed by 2 companies.
gocovri evidence translation
What we can confirm
No verified FDA or trial count is available.
What it means
More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.
What to watch
Evidence is limited; missing information remains unknown.
BioSniper AIPage evidence connected
Prepared research question
What is verified about gocovri, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapyTreatment of dyskinesia in patients with Parkinson's Disease (PD) receiving levodopa-based therapy, and as an adjunctive treatment to levodopa/carbidopa in patients with PD experiencing "OFF" episodes
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Adamas Pharmaceuticals Inc (ADMS) treatment of dyskinesia in patients with Parkinson's disease… | Approved |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) Treatment of dyskinesia in patients with Parkinson's Disease… | Approved |